| 貨號 | 規(guī)格 | 價格 | 上海 | 北京 | 武漢 | 南京 | 購買數(shù)量 |
|---|---|---|---|---|---|---|---|
S80840-100mg |
98.3% | ￥350.00 | 1 | - | - | - |
|
S80840-500mg |
≥98% | ￥1400.00 | 貨期：2-3天 | - | - | - |
|
Carmofur is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer. Carmofur has been known to induce leukoencephalopathy.
| 產(chǎn)品描述： | Carmofur is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer. Carmofur has been known to induce leukoencephalopathy. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點： | DNA/RNA Synthesis;Nucleoside Antimetabolite/Analog;SARS-CoV;Virus Protease;NucleosideAntimetabolite/Analog;VirusProtease;SARS-CoV;DNA/RNASynthesis | ||||||||||||||||||||
| 參考文獻： | 1.Bowden G D, Land K M, O'Connor R M, et al. High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth[J]. International Journal for Parasitology: Drugs and Drug Resistance. 2018 Apr；8(1): 137-144. 2.Akiba T, et al. Acta Neuropathol,1996, 92(1), 8-13. 3.Sato S, et al. Gan To Kagaku Ryoho,1999, 26(11), 1613-1616. 4.Kuzuhara S, et al. J Neurol,1987, 234(6), 365-370. | ||||||||||||||||||||
| 溶解性： | H2O:<1 mg/mL Ethanol:10 mg/mL (38.87 mM) DMSO:49 mg/mL (190.5 mM) | ||||||||||||||||||||
| 保存條件： | 2-8℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網(wǎng)安備 31011702002021號
危險品化學(xué)品經(jīng)營許可證（不帶存儲）
營業(yè)執(zhí)照(三證合一)
北京